Sinusitis Treatment Market Top Key Players - Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., Abbott Laboratories Inc., Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Inc., Pfizer Inc., Janssen Pharmaceuticals Inc. and Dr. Re

According to a new report published by xResearch, titled, "Sinusitis Treatment Market 2022- Industry Insights, Trends, Opportunity & Forecast, 2021-2030," the global sinusitis treatment market size is anticipated to witness moderate growth during the forecast period i.e. 2022-2030.

The growing number of upper respiratory tract infections among people, the increasing patient base of common cold and sinusitis, the rising pollution levels and the augmenting demand for the development of advanced antibiotics are among the predominant factors contributing towards the growth of the global sinusitis treatment market.

Download Request for Sample@ https://www.xresearch.biz/request-sample-pages/sinusitis-treatment-market

According to treatment, the antihistamines sub-segment accounted for more than 32.0% market share and led the global sinusitis treatment market in 2021 followed by the antibiotics segment. On the other hand, the decongestant & mucolytic and NSAIDS segments are predicted to register the fastest growth in the market during the forecast period of 2022-2030.

According to disease, the acute sinusitis segment held 36.0% market share and led the global sinusitis treatment market in 2021. The segment is expected to continue with this trend over the forecast period by expanding at a growth rate of 4.1%. According to route of administration, the oral segment dominated in global sinusitis treatment market in 2021 by holding a market share of 61.0%. It is estimated that segment will further retain its dominance in the market over the estimated time frame of 2022-2030.

According to distribution channel, the retail pharmacies segment held the largest market share of 45.0% in the global sinusitis treatment market in 2021 and is anticipated to further maintain the trend over the forecast period. On the other hand, the hospital pharmacies segment is projected to attain the highest CAGR in the market during the forecast period.

Geographically, the North American region dominated in the global sinusitis treatment market in 2021 followed by the European region. The region's position is anticipated to remain unchanged during the forecast period owing to a host of factors including the burgeoning prevalence of sinusitis and chronic diseases, the surging awareness levels among people and the presence of key players in the region.

The Asia Pacific region is expected to register growth at the highest CAGR in the global sinusitis treatment market over the forecast period. The proliferating cases of acute bacterial sinusitis infection, the expanding healthcare infrastructure, the rising healthcare expenditure and the escalating number of R&D activities in the region are among the major factors propelling the growth of the market in the region.

Some of the major sinusitis treatment companies profiled in the report include Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., Abbott Laboratories Inc., Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Inc., Pfizer Inc., Janssen Pharmaceuticals Inc. and Dr. Reddy's Laboratories Inc.

The global sinusitis treatment market is segmented into disease, treatment, route of administration, distribution channel and region. Based on disease, the market is bifurcated into acute sinustitis, sub-acute sinusitis and chronic sinusitis. Based on treatment, it is classified into analgesics, antibiotics, NSAIDS, desongestant and mucolytic, nasal irrigation and surgery.

The antibiotics segment is further categorized into penicillin/b-lactamase inhibitor combinations, macrolide, quinolone and cephalosporin. The decongestant and mucolytic segment is further categorized into corticosteroids, antihistamines, a1 receptor agonist and imidazoline derivatives. The surgery segment is further categorized into endoscopy and balloon sinusplasty. Based on route of administration, it is classified into topical, nasal, oral and injectable. Based on distribution channel, it is classified into online pharmacies, retail pharmacies and hospital pharmacies.

The global sinusitis treatment market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).

Key Insights of Sinusitis Treatment Market

• On the basis of disease, the acute sinusitis segment held 36.0% market share and led the global sinusitis treatment market in 2021.

• On the basis of route of administration, the oral segment dominated in global sinusitis treatment market in 2021 by holding a market share of 61.0%.

• On the basis of distribution channel, the retail pharmacies segment held the largest market share of 45.0% in the global sinusitis treatment market in 2021. The hospital pharmacies segment is projected to attain the highest CAGR in the market during the forecast period.

• On the basis of treatment, the antihistamines sub-segment accounted for more than 32.0% market share and led the global sinusitis treatment market in 2021 followed by the antibiotics segment. The decongestant & mucolytic and NSAIDS segments are predicted to register the fastest growth in the market during the forecast period of 2022-2030.

• On the basis of region, North America dominated in the global sinusitis treatment market in 2021 followed by the European region. The region's position is anticipated to remain unchanged during the forecast period.

• On the basis of region, Asia Pacific is expected to register growth at the highest CAGR in the global sinusitis treatment market over the forecast period.

Read More Information: https://www.xresearch.biz/shop/sinusitis-treatment-market

Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545

About Us:-
xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

This release was published on openPR.